Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-09-18

FDA Approved: GEMFIBROZIL — Supplemental Application (NorthStar Rx LLC)

View source ↗

Summary

FDA approved a supplemental ANDA for Gemfibrozil from NorthStar Rx LLC, confirming regulatory approval of a generic Gemfibrozil product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gemfibrozil (Gemfibrozil)

Snippet

SUPPL AP for GEMFIBROZIL (GEMFIBROZIL)